Jiráček J - Search Results

1

Targeting the insulin receptor with hormone and peptide dimers.

Lin J, Selicharová I, Mitrová K, Fabre B, Miriyala VM, Lepšík M, Jiráček J, Hernández MSG. Lin J, et al. Among authors: jiracek j. J Pept Sci. 2023 Apr;29(4):e3461. doi: 10.1002/psc.3461. Epub 2022 Nov 14. J Pept Sci. 2023. PMID: 36336650

2

Inhibition of betaine-homocysteine S-methyltransferase causes hyperhomocysteinemia in mice.

Collinsova M, Strakova J, Jiracek J, Garrow TA. Collinsova M, et al. Among authors: jiracek j. J Nutr. 2006 Jun;136(6):1493-7. doi: 10.1093/jn/136.6.1493. J Nutr. 2006. PMID: 16702310 Free article.

3

Dissecting the catalytic mechanism of betaine-homocysteine S-methyltransferase by use of intrinsic tryptophan fluorescence and site-directed mutagenesis.

Castro C, Gratson AA, Evans JC, Jiracek J, Collinsová M, Ludwig ML, Garrow TA. Castro C, et al. Among authors: jiracek j. Biochemistry. 2004 May 11;43(18):5341-51. doi: 10.1021/bi049821x. Biochemistry. 2004. PMID: 15122900

4

Protection of the Hydroxyphosphinyl Function of Phosphinic Dipeptides by Adamantyl. Application to the Solid-Phase Synthesis of Phosphinic Peptides.

Yiotakis A, Vassiliou S, Jirácek J, Dive V. Yiotakis A, et al. Among authors: jiracek j. J Org Chem. 1996 Sep 20;61(19):6601-6605. doi: 10.1021/jo9603439. J Org Chem. 1996. PMID: 11667528

5

How insulin engages its primary binding site on the insulin receptor.

Menting JG, Whittaker J, Margetts MB, Whittaker LJ, Kong GK, Smith BJ, Watson CJ, Záková L, Kletvíková E, Jiráček J, Chan SJ, Steiner DF, Dodson GG, Brzozowski AM, Weiss MA, Ward CW, Lawrence MC. Menting JG, et al. Among authors: jiracek j. Nature. 2013 Jan 10;493(7431):241-5. doi: 10.1038/nature11781. Nature. 2013. PMID: 23302862 Free PMC article.

6

Insulin and insulin-like growth factor II differentially regulate endocytic sorting and stability of insulin receptor isoform A.

Morcavallo A, Genua M, Palummo A, Kletvikova E, Jiracek J, Brzozowski AM, Iozzo RV, Belfiore A, Morrione A. Morcavallo A, et al. Among authors: jiracek j. J Biol Chem. 2012 Mar 30;287(14):11422-36. doi: 10.1074/jbc.M111.252478. Epub 2012 Feb 8. J Biol Chem. 2012. PMID: 22318726 Free PMC article.

7

Development of highly potent and selective phosphinic peptide inhibitors of zinc endopeptidase 24-15 using combinatorial chemistry.

Jirácek J, Yiotakis A, Vincent B, Lecoq A, Nicolaou A, Checler F, Dive V. Jirácek J, et al. J Biol Chem. 1995 Sep 15;270(37):21701-6. doi: 10.1074/jbc.270.37.21701. J Biol Chem. 1995. PMID: 7665587 Free article.

8

RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites.

Dive V, Cotton J, Yiotakis A, Michaud A, Vassiliou S, Jiracek J, Vazeux G, Chauvet MT, Cuniasse P, Corvol P. Dive V, et al. Among authors: jiracek j. Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4330-5. doi: 10.1073/pnas.96.8.4330. Proc Natl Acad Sci U S A. 1999. PMID: 10200262 Free PMC article.

9

Effect of a novel selective and potent phosphinic peptide inhibitor of endopeptidase 3.4.24.16 on neurotensin-induced analgesia and neuronal inactivation.

Vincent B, Jiracek J, Noble F, Loog M, Roques B, Dive V, Vincent JP, Checler F. Vincent B, et al. Among authors: jiracek j. Br J Pharmacol. 1997 Jun;121(4):705-10. doi: 10.1038/sj.bjp.0701182. Br J Pharmacol. 1997. PMID: 9208137 Free PMC article.

10

Development of the first potent and selective inhibitor of the zinc endopeptidase neurolysin using a systematic approach based on combinatorial chemistry of phosphinic peptides.

Jirácek J, Yiotakis A, Vincent B, Checler F, Dive V. Jirácek J, et al. J Biol Chem. 1996 Aug 9;271(32):19606-11. doi: 10.1074/jbc.271.32.19606. J Biol Chem. 1996. PMID: 8702656 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page